Related Experiment Video
Updated: Oct 29, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
Emir Kobic1, Christian M Gill2, A Brian Mochon3,4
1Department of Pharmacy, Banner University Medical Center, Phoenix, Arizona, USA.
Abstract:
Antimicrobial dosing in patients receiving continuous renal replacement therapy is a continued clinical challenge. We describe a case of a patient receiving cefiderocol 2 g intravenously every 8 hours as a 3-hour infusion for a multidrug-resistant Pseudomonas aeruginosa pneumonia and bacteremia while undergoing continuous venovenous hemodiafiltration. The clinical course and cefiderocol pharmacokinetics are described.
Insights
Optimizing cefiderocol dosing for patients on continuous renal replacement therapy (CRRT) is crucial. This case study examines cefiderocol pharmacokinetics in a patient with multidrug-resistant Pseudomonas aeruginosa infection undergoing CRRT.
Area of Science:
- Pharmacology
- Infectious Diseases
- Nephrology
Background:
- Antimicrobial dosing presents challenges in patients undergoing continuous renal replacement therapy (CRRT).
- Effective treatment of multidrug-resistant organisms requires careful pharmacokinetic consideration.
- Pseudomonas aeruginosa infections necessitate robust therapeutic strategies.
Observation:
- A patient with multidrug-resistant Pseudomonas aeruginosa pneumonia and bacteremia was treated with cefiderocol.
- The patient received cefiderocol 2 g intravenously every 8 hours as a 3-hour infusion.
- Continuous venovenous hemodiafiltration (CVVHDF) was administered concurrently.
Findings:
- The clinical course of the patient was monitored.
- Cefiderocol pharmacokinetics were evaluated during CVVHDF.
- This provides insight into cefiderocol elimination and dosing in CRRT.
Implications:
- Understanding cefiderocol pharmacokinetics in CRRT is vital for effective patient management.
- This case may inform future dosing guidelines for cefiderocol in critically ill patients with renal impairment.
- Optimized dosing can improve clinical outcomes for severe infections in CRRT patients.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...